Evidence map›Paper›PMID 42582143›Full record

ReviewInnovation (Cambridge (Mass.))2026

Dilating the aging clock with light.

Jessica Jing Yi Chang, Ivan Yee Man Ho, Clarissa Bernice Quah, Yu Yin Bai, Jiahe Ren, Aaron Song Chuan Foo, Daniel Boon Loong Teh

Abstract readReview
In one paragraph

Review in Innovation (Cambridge (Mass.)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica Jing Yi ChangDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore S117597, Singapore.
Ivan Yee Man HoDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore S117597, Singapore.
Clarissa Bernice QuahNeurobiology Program, Life Sciences Institute, National University of Singapore, Singapore S117456, Singapore.
Yu Yin BaiDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore S117597, Singapore.
Jiahe RenDepartment of Biomedical Engineering, College of Design & Engineering, National University of Singapore, Singapore S117575, Singapore.
Aaron Song Chuan FooDivision of Neurosurgery, Department of Surgery, National University Hospital, National University Health System, Singapore S119074, Singapore.
Daniel Boon Loong TehDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore S117597, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise and rapid modeling of aging remains a significant challenge. This review explores the potential of emerging light-based technologies-including direct light exposure, photodynamic therapy (PDT), and optogenetics-as accelerated, mechanistically targeted models for interrogating aging processes. Unlike conventional methods that rely on chronologically aged organisms or non-specific stressors, these light-driven approaches can induce specific hallmark aging phenotypes within days. This offers unprecedented temporal and spatial control, allowing researchers to precisely trigger and define molecular pathways, such as localized oxidative bursts or programmed protein interactions. Such capabilities provide a powerful platform for testing causal hypotheses about aging, especially organ-specific aging. The review also outlines a framework connecting each light modality to aging, including cellular senescence, telomere attrition, proteostasis loss, and epigenetic drift. It discusses a mechanistic matrix linking each light modality to specific molecular targets and age-associated outcomes. Light-based platforms, when combined with genetic and pharmacological tools, are poised to accelerate discovery in aging by enabling high-throughput and organelle-specific perturbation of aging biology. These approaches could ultimately redefine how we experimentally dissect and potentially modulate the aging process either by rapidly recapitulating aging features for study or by revealing leverage points to slow aging.

Indexed as

aging modelnatural agingoptogeneticphotoagingphotodynamicUV light

Identifiers

PMID42582143
PMCPMC13457181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.